The impact of chemotherapy dose adjustment and delay in patients with leukemias and lymphomas who exercise

This review addresses the critical challenge of leukemia and lymphoma, delving into the epidemiology, treatment adherence, impact of physical activity, and the pressing need for more effective chemotherapy protocols. The purpose is to synthesize current knowledge, highlight existing gaps, and emphas...

Full description

Saved in:
Bibliographic Details
Main Authors: Bartłomiej Szymański (Author), Szymon Piaszczyński (Author), Kacper Płeska (Author), Joanna Wojtania (Author), Michał Łepik (Author), Zofia Uszok (Author), Krzysztof Rosiak (Author), Kacper Reguła (Author), Kamil Waloch (Author), Andrzej Czajka (Author)
Format: Book
Published: Nicolaus Copernicus University in Toruń, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3d206c0b0eb542adb3ee049b55ce4bc8
042 |a dc 
100 1 0 |a Bartłomiej Szymański  |e author 
700 1 0 |a Szymon Piaszczyński  |e author 
700 1 0 |a Kacper Płeska  |e author 
700 1 0 |a Joanna Wojtania  |e author 
700 1 0 |a Michał Łepik  |e author 
700 1 0 |a Zofia Uszok  |e author 
700 1 0 |a Krzysztof Rosiak  |e author 
700 1 0 |a Kacper Reguła  |e author 
700 1 0 |a Kamil Waloch  |e author 
700 1 0 |a Andrzej Czajka  |e author 
245 0 0 |a The impact of chemotherapy dose adjustment and delay in patients with leukemias and lymphomas who exercise 
260 |b Nicolaus Copernicus University in Toruń,   |c 2024-06-01T00:00:00Z. 
500 |a 10.12775/QS.2024.21.51462 
500 |a 2450-3118 
520 |a This review addresses the critical challenge of leukemia and lymphoma, delving into the epidemiology, treatment adherence, impact of physical activity, and the pressing need for more effective chemotherapy protocols. The purpose is to synthesize current knowledge, highlight existing gaps, and emphasize the importance of innovation in patient care strategies. Epidemiological data show variability in incidence rates and underscore the roles age, genetics, and lifestyle play in disease risk and progression. These insights are vital for effective prevention and timely intervention.  The focus of the discussion revolves around the development of chemotherapy protocols. Tailoring these to the individual's genetic and cancer profile can lead to significant gains in efficacy and minimize unwanted side effects, crucially improving patient quality of life and compliance.  Treatment adherence is fundamental to successful outcomes, requiring multifaceted support strategies. Education, side-effect management, and addressing care barriers are pivotal in ensuring patients fully benefit from therapy. Personalization in chemotherapy protocol development is a current focus, aiming to maximize efficacy while minimizing side effects to improve quality of life and survival. The conclusion advocates for an integrated approach combining research and clinical practice to cater to the biological intricacies of both the malignancy and the patient. Progress in these areas proclaims a future where personalized, effective, and compassionate cancer treatment is the norm, pushing us closer to the goal of transforming cancer into a manageable condition.  
546 |a EN 
690 |a Chemotherapy 
690 |a delays 
690 |a oncology 
690 |a physical activity 
690 |a leukemia 
690 |a lymphoma 
690 |a Sports 
690 |a GV557-1198.995 
690 |a Sports medicine 
690 |a RC1200-1245 
655 7 |a article  |2 local 
786 0 |n Quality in Sport, Vol 21 (2024) 
787 0 |n https://apcz.umk.pl/QS/article/view/51462 
787 0 |n https://doaj.org/toc/2450-3118 
856 4 1 |u https://doaj.org/article/3d206c0b0eb542adb3ee049b55ce4bc8  |z Connect to this object online.